Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis

American Journal of the Medical Sciences

Volumn 337, Issue 3, 2009, Pages 161-164

  Reddymasu, Savio C ^a   Singh, Shailender ^a   Sankula, Rajakumar ^a   Lavenbarg, Teri A H ^a   Olyaee, Mojtaba ^a   McCallum, Richard W ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Botulinum toxin A; Gastroparesis; Pyloroplasty; Vagotomy

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; LAPAROTOMY; MALE; POSTOPERATIVE COMPLICATION; PYLORUS; STOMACH FUNDOPLICATION; STOMACH PARESIS; TREATMENT OUTCOME; VAGOTOMY; GASTROSCOPY; INJECTION; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; GASTROPARESIS; GASTROSCOPY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PYLORUS; VAGOTOMY;

EID: 63249101517     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318182ee33     Document Type: Article

References (27)

1. Parkman HP, Hasler WL, Fisher RS. American gastroenterological association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004;127:1592-1622 (Pubitemid 39457783)
2. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol 2006;101:1129-1139
3. Abell TL, Bernstein VK, Cutts T, et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006;18: 263-283
4. Chung SA, Rotstein O, Greenberg GR, et al. Mechanisms coordinating gastric and small intestinal mmc: role of extrinsic innervation rather than motilin. Am J Physiol 1994;267:G800-G809. (Pubitemid 2163909)
5. Bromer MQ, Friedenberg F, Miller LS, et al. Endoscopic pyloric injection of botulinum toxin a for the treatment of refractory gastroparesis. Gastrointest Endosc 2005;61:833-839 (Pubitemid 40779413)
6. Lacy BE, Crowell MD, Schettler-Duncan A, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 2004;27:2341-2347 (Pubitemid 39281383)
7. Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002;55: 920-923 (Pubitemid 41127918)
8. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90:1919-1925 (Pubitemid 16085599)
9. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000;106:803. (Pubitemid 30655637)
10. Mashimo H, Kjellin A, Goyal RK. Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice. Gastroenterology 2000;119: 766-773 (Pubitemid 30681136)
11. Lin HC, Prather C, Fisher RS, et al. Measurement of gastrointestinal transit. Dig Dis Sci 2005;50:989-1004.
12. Koop H, Arnold R, Creutzfeldt W. Pancreatic polypeptide and gastrin release during sham feeding in man. Digestion 1984;30:47-52. (Pubitemid 14053111)
13. Balaji NS, Crookes PF, Banki F, et al. A safe and noninvasive test for vagal integrity revisited. Arch Surg 2002;137:954-8; discussion 958-959 (Pubitemid 34851893)
14. Gaddipati KV, Simonian HP, Kresge KM, et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 2006;51:1339-1346
15. Arts J, Bisschops R, Caenepeel P, et al. A placebo-controlled cross-over study of intrapyloric injection of botulinum toxin in diabetic or postsurgical gastroparesis. Aliment Pharmacol Ther 2007;26:1251-1258 (Pubitemid 47620416)
16. Friedenberg F, Palit A, Parkman H, et al. Randomized, placebo-controlled trial of botulinum toxin a for the treatment of delayed gastric emptying. Gastroenterology 2007;132:A-372. [#1151]
17. Emas S, Grupcev G, Eriksson B. Six-year results of a prospective, randomized trial of selective proximal vagotomy with and without pyloroplasty in the treatment of duodenal, pyloric, and prepyloric ulcers. Ann Surg 1993;217:6-14. (Pubitemid 23033212)
18. Holle F. Adequate selective proximal vagotomy with pyloroplasty as nonresective surgery for peptic ulcer disease: a 20 year review. Int Surg 1983;68:295-298 (Pubitemid 14188093)
19. Holle FK. The physiopathologic background and standard technique of selective proximal vagotomy and pyloroplasty. Surg Gynecol Obstet 1977;145:853-859 (Pubitemid 8241887)
20. Kozarek RA, Low DE, Raltz SL. Complications associated with laparoscopic anti-reflux surgery: one multispecialty clinic's experience. Gastrointest Endosc 1997;46:527-531 (Pubitemid 28018548)
21. Vittal H, Pasricha PF. Botulinum toxin for gastrointestinal disorders: therapy and mechanisms. Neurotox Res 2006;9:149-159
22. Waisbren SJ, Modlin IM, Lester R. Dragstedt and his role in the evolution of therapeutic vagotomy in the united states. Am J Surg 1994;167:344-359
23. Velanovich V. Esophagogastrectomy without pyloroplasty. Dis Esophagus 2003;16:243-245
24. Dong K, Yu XJ, Li B, et al. Advances in mechanisms of postsurgical gastroparesis syndrome and its diagnosis and treatment. Chin J Dig Dis 2006;7:76-82.
25. Golder S, Herfarth H, Kullmann F. Failure of capsule transportation due to gastroparesis after gastric truncal vagotomy. Endoscopy 2005; 37:397-398 (Pubitemid 40561668)
26. Tobi M, Holtz T, Carethers J, et al. Delayed gastric emptying after laparoscopic anterior highly selective and posterior truncal vagotomy. Am J Gastroenterol 1995;90:810-811
27. Skellenger ME, Jordan PH Jr. Complications of vagotomy and pyloroplasty. Surg Clin North Am 1983;63:1167-1180